Jung Choi
Director/Miembro de la Junta en ANNEXON, INC. .
Fortuna: - $ al 30/04/2024
Perfil
Ms. Jung E.
Choi is an Independent Director at Annexon, Inc., a Chief Business & Strategy Officer at Global Blood Therapeutics, Inc. and a Member at Aspen Global Leadership Network.
She is on the Board of Directors at Annexon, Inc. Ms. Choi was previously employed as a Senior Vice President-Corporate Development by InterMune, Inc., a Senior Vice President-Corporate Development by Chimerix, Inc., a Head-Corporate Development by Gilead Sciences, Inc., a Vice President by Bay City Capital LLC, and an Engagement Manager by McKinsey & Co., Inc. She received her undergraduate degree from Stanford University and an MBA from Stanford University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ANNEXON, INC.
-.--% | 01/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Jung Choi
| Empresas | Cargo | Inicio |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2015 |
| ANNEXON, INC. | Director/Miembro de la Junta | 01/06/2020 |
| Aspen Global Leadership Network | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Jung Choi.
| Empresas | Cargo | Fin |
|---|---|---|
| INTERMUNE INC | Corporate Officer/Principal | 01/03/2015 |
| CHIMERIX, INC. | Corporate Officer/Principal | 01/01/2013 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2010 |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Corporate Officer/Principal | 01/01/2001 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1999 |
Formación de Jung Choi.
| Stanford University | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| ANNEXON, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
| Aspen Global Leadership Network |
- Bolsa de valores
- Insiders
- Jung Choi
